Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
Whether the cancer was completely removed by surgery
Cardiovascular disease and risk management: standards of care in diabetes-2023
In 2025, compounding surged in the US as a workaround during GLP-1 shortages, with telehealth providers stepping in to meet demand
Evening dosing considerations Some people prefer evening dosing because morning nausea is a common side effect during the first weeks
Worrying about vision problems is normal when asking, Can tirzepatide cause blindness, since this medication has effects on blood sugar and metabolism
